Singh, A., Saharan, V., Singh, M., Bhandari, A. (2011). Phytosome: Drug Delivery System for Polyphenolic Phytoconstituents. Iranian Journal of Pharmaceutical Sciences, 7(4), 209-219.
Anupama Singh; Vikas Anand Saharan; Manjeet Singh; Anil Bhandari. "Phytosome: Drug Delivery System for Polyphenolic Phytoconstituents". Iranian Journal of Pharmaceutical Sciences, 7, 4, 2011, 209-219.
Singh, A., Saharan, V., Singh, M., Bhandari, A. (2011). 'Phytosome: Drug Delivery System for Polyphenolic Phytoconstituents', Iranian Journal of Pharmaceutical Sciences, 7(4), pp. 209-219.
Singh, A., Saharan, V., Singh, M., Bhandari, A. Phytosome: Drug Delivery System for Polyphenolic Phytoconstituents. Iranian Journal of Pharmaceutical Sciences, 2011; 7(4): 209-219.
Phytosome: Drug Delivery System for Polyphenolic Phytoconstituents
1Assistant Professor & Head, Department of Pharmacognosy, Jodhpur National University, Boranada, Jodhpur, Rajasthan, India.
2Sardar Bhagwan Singh Post Graduate Institute of Biomedical Sceinces and Research, Balawala, Dehradun, Uttarakhand, India
3Jodhpur National University, Boranada, Jodhpur, Rajasthan, India.
Abstract
Several plant extracts and phytoconstituents, despite having excellent bioactivity in vitro, demonstrate less or no in vivo actions due to their poor lipid solubility or improper molecular size or destruction in gut. Drug delivery system for polyphenolic phytoconstituents (phytosomes) was prepared by complexing polyphenolic phytoconstituents with phospholipid mainly phosphatidylcholine which bind components to each other on a molecular level. Bioavailability is enhanced due to their capacity to cross the lipid rich bio-membranes and to protect the valuable components of the herbal extract from destruction by digestive secretions and gut bacteria. Phytosomes have the capacity to deliver the standardized plant extracts and phytoconstituents through several routes of drug administration. Only a few natural drugs have been formulated and are available in the market as phytosomes. With wide range of applications of phytosomes numerous studies are undergoing and lots more is expected in the forthcoming years. The techniques used for such formulations are patentable and highly profitable.
Phytosomes, complex of natural active ingredients and phospholipid(s), increase absorption of herbal extracts or isolated active ingredients when applied topically or orally. Phytosomes are cell like structures which result from the stoichiometric reaction of the phospholipids (phosphatidylcholine, phosphatidylserine, etc.) with the standardized extract or polyphenolic constituents (like flavonoids, terpenoids, tannins, xanthones) in a non-polar solvent, which are better absorbed, utilized and as a result produce better results than conventional herbal extracts [1-3].Phospholipids are the main building blocks of life and are one of the major components of cellular membranes. In general, they are considered as natural digestive aid and carriers for both polar and non-polar active substances [4, 5]. Most of phospholipids possess nutritional properties, like phosphatidylserine which acts as a brain cell nutrient, phosphatidylcholine which is important in liver cell regeneration. Soya phospholipids have lipid reducing effect and hydrogenated phospholipids serve as basis for preparation of stable liposomes because of their amphiphilic charater [4, 6].
Many plant extracts and phytochemical constituents possess excellent biological activity in vitro, but demonstrate less or no in vivo activity due to inherent property of drug constituents like poor lipid solubility, improper molecular size, destruction in gut, etc. [1]. These problems lead to decreased absorption. Decreased absorption problems can be alleviated by preparing complexes with phospholipids. Thus, phytosomal formulations enhance the bioavailability of active phytochemical constituents as they are now permeable and can cross the lipid rich bio-membranes quite easily, and the active components of the herbal extracts are well protected from destruction by digestive secretions and gut bacteria.Therefore, with help of phytosomal preparations, the amount of standardized plant extracts and phytoconstituents administered in body through several routes are required in less amount for good therapeutic activity [2].
With the advancements in science, the phytosomes have gained importance in various fields like pharmaceuticals, cosmeceuticals and nutraceuticals in preparing different formulations such as solutions, emulsion, creams, lotions, gels, etc. Several companies involved in production and marketing of phytosomal products are Indena, Jamieson natural resources, Thorne Research, Natural factors, and Natures herb [7]. Some of the marketed formulations are shown in Table 1.
Table 1.Marketed Phytosomal Products.
Natural sources
Phytoconstituents complexed
Phytosomal products
Dose and Dosage form
Mechanism of action
Utilization
References
Silybium maranium (Milk Thistle)
Silybin, Silycristin, Isosilbin, silydianin.
Silybin PhytosomeTM
(Siliphos®)
120-200 mg
Emulsion, gel, lotion and cream.
Prevents the destruction of glutathione in liver.
Hepatoprotective, hepatitis, cirrhosis and inflammation.
[8, 22-24]
Panax ginseng
(Ginseng)
Ginsenosides
Ginseng PhytosomeTM
150 mg
Increases catalase, superoxide dismutase, glutathione peroxidase and glutathione reductase activities and prevent depletion of these antioxidant enzymes.
Inhibits urokinase enzyme which is responsible for increase in tumour size. Enhances the antioxidant mechanisms by increasing the activity of enzymes such as glutathione peroxidase and catalase.
Enhances release of neuro- transmitters like catecholamines and inhibits catechol-O-methyl transferase and MAO. Dilatation of capillaries and arterioles, thus improves delivery of nutrients to skin.
Ginkolides inhibits the binding of platelet activating factor to its platelet membrane receptor.
Gingko flavanoids inhibits cAMP phosphodiesterase enzyme thus improves lipolysis in fat cells and capillary blood flow.
cAMP-independent mechanism, digitalis-like effect on the Na+/K+-ATPase in human cardiac muscle tissue
Inhibits angiotensin converting enzyme.
Nutraceutical, Cardioprotective and antihypertensive
[8]
Olea europaea
(Olive tree)
Verbascoside, tyrosol, hydroxytyrosol
Oleaselect PhytosomeTM
-
Decreases concentration of free radicals and level of lipid peroxidation.
Inhibits topoisomerase II, protein kinase C and telomerase.
Selective inhibitor of 5-Lipooxygenase.
Antioxidant, antihyperlipidimic, anticancer and anti-inflammatory.
[5]
Echniacea angustifolia
(Cone flower)
Echinacosides and high molecular weight polysaccharide (Inulin).
Echniacea PhytosomeTM
-
Mechanism of action not clear but it is believed to stimulate cellular and hormonal immune defence, activates B and T lymphocytes and stimulates tissue necrosis factor.29
Glycyhrretinic acid is structuraly similar to cortisol, it potentiates the anti-inflammatory activity of cortisol by inhibiting its intracellular inactivation.
Protective activity on microcirculation, with reduction of abnormal increase in capillary permeability.
Skin disorders, antiulcer, wound healing, anti-hair loss agent.
[8]
Curcuma longa
(Turmeric)
Curcumin
Curcumin PhytosomeTM
Curcuvet®
(Meriva®)
250 mg and 360 mg
Inhibit arachidonic acid metabolism, cyclooxygenase, lipoxygenase, cytokines, tissue necrosis factor and release of steroidal hormones. It stabilizes lysosomal membrane and cause uncoupling of oxidative phosphorylation.
Anti-inflammatory, osteoarthritis, anticancer
[24, 29]
Citrus aurantium (Bitter orange)
Naringenin.
Naringenin PhytosomeTM
100mg/kg
Increase the activity of glutahione peroxidase, superoxide dismutase, catalase.
Antioxidant
[8, 30]
Aesculus hippocastanum
(Horse Chestnut tree)
Saponins
Escin β-sitosterol Phytosome TM
3% gel
shampoo, hair conditioner, toothpaste, mouthwashe, and lotion
Modifies the vascular permeability.
Anti-oedema, and vasoactive properties
[8]
Swertia alternifolia
Xanthones 26
Swertia PhytosomeTM
-
-
[31]
Vaccinum myrtillus (Bilberry)
Anthocyanosides
Mirtoselect PhytosomeTM
-
Reduces capillary permeability and increase capillary resistance and also inhibits proteolytic enzymes.
Inhibits cyclooxygenase, 5-α reductase and lipooxygenase, smooth muscle relaxant. Inhibits specific components of the IGF-I signalling pathway, and induces JNK activation. α-Adrenoreceptor antagonist.
Non- Cancerous prostate enlargement
[5]
Melilotus officinalis
(Sweet clover)
Melilotoside, Flavanoids and terpenoids
LymphaselectTM
2 to 60 mg
Modifies the vascular permeability.
Anti-inflammatory, antioedema, thrombophlebitis.
[5]
Ammi visnaga
( Khella)
Visnadine
VisnadexTM
Cream, emulsion, lotion, gel
Antiphosphodiesterase activity, Concentration of cAMP increases which causes activation of lipases and improves lipolysis in fat cells.
Microcirculation improver, anticellulite
[8]
Santalum album
(Sandal wood)
Ximenynic acid,
ethyl ximenynate
Ximilene and Ximenoil PhytosomeTM
Emulsion, lotion, gel
Increases the conversion of arachidonic acid into eicosanoids in the dermis which is related with a vasokinetic action and further with an increase of the microcirculation..
Microcirculation improver
[8]
Fraxinus ornus
(Flowering ash)
Esculoside (Esculin)
Esculoside PhytosomeTM
Emulsion
Improves capillary permeability and fragility Inhibits catabolic enzymes such as hyaluronidase and collagenase, thus preserves the integrity of connective tissue.
Inhibits the activation of both Hypoxia inducible factor -1 α and tumor necrosis factor- α. Increases superoxide dismutase activity and decreases the lipid peroxidation.
Antiinflammatory, cardiovascular diseases
[33-36]
Zanthoxylum bungeanum
(Tumburu)
Hydroxy-a-sanshool
Zanthalene PhytosomeTM
Emulsion and lotion
Blocks sodium channels.
Reduces transmission of the impulse that causes pain.
Soothing and anti-reddening.
[8]
Glycine max
(Soy)
Genistein anddaidzein
Soyselect PhytosomeTM
400 mg/day (Suggested Dose)
Inhibits polymorphonuclear leukocytes adhesion to activated platelets
Antiangiogenic, anticarcinogenic,cardioprotective , immunostimulato and hypochole-sterolemic
2. Phytosome vs liposome: similarities and differences
A liposome is formed by mixing a water-soluble substance with phosphatidylcholine. No chemical bond is formed; molecules of phosphatidylcholine collectively surround the water-soluble substance. Hundreds or even thousands of phosphatidylcholine molecules surround the water-soluble compound. In contrast, phytosome is formed by mixing a water-soluble substance with phosphatidylcholine and here chemical bond is formed between individual plant components and phosphatidylcholine.Soichiometric 1:1 or 2:1 complexes form which depend on the extract or phytoconstituent and the phospholipid used. This difference results in increased absorption of active constituents from phytosome than from liposomes [2, 3, 8, 9].
Figure 1. Preparation of phytosomes.
3. Strenghts of phytosome [2, 4, 9-11]
v Phytosomes show better stability as chemical bond is formed between phsospholipid molecule and phytoconstituent(s).
v Dose of phytoconstituents is reduced due to more bioavailability of the phytoconstituents in the complex form.
v Duration of action is increased.
v Phytoconstituents complex with phospholipids are more stable in gastric sections and resist the action of gut bacteria.
v Enhanced permeability of phytoconstituents across the biological membranes.
v Absorption of lipid insoluble polar phytoconstituents through different routes shows better absorption, hence shows significantly higher therapeutic effects.
v Phoshatidylcholine used in the formation of phytosomes, besides acting as a carrier also possess several therapeutic properties, hence gives the synergistic effect when particular substance is given.
v Drug entrapment is not a problem with phytosome as the complex is biodegradable
4. Production methodology
Phytosome, phospholipid complexes of vegetable extracts as shown in Figure 1 are prepared by adding the aqueous extracts to phospholipid dissolved in a suitable solvent such as ethyl acetate, acetone, ethanol under reflux and stirring. The resulting suspension is concentrated by reduced pressure to a thick residue which can be dried and ground. Natural, synthetic or semi-synthetic phospholipids have also been reported to form complexes with purified components of the vegetable extracts [8].
5. Principle
Phosphatidylcholine (or phosphatidylserine) is a bifunctional compound. The phosphatidyl moiety is lipophilic and the choline (serine) moiety is hydrophilic in nature. This dual solubility of the phospholipid makes it an effective emulsifier. Thus, the choline head of the phosphatidylcholine molecule binds to these compounds while the lipid soluble phosphatidyl portion comprising the body and tail which then surrounds the choline bound material. Hence, the phytoconstituents produce a lipid compatible molecular complex with phospholipids, as shown (also called as phytophospholipid complex) [9].
6. Patents of phytosome technology
Bioavailability of phenols in human volunteers was 3-5 times more when administered in complexed form with phospholipids (Oleaselected TM Phytosome®) [12]. Phospholipids to olive fruits and leave extract ratio in the prepared complexes was in the range of 10 to 1%(w/w). Phospholipid complexes of curcumin provided five times higher peak plasma levels and AUC in male Wistar rats when compared to peak plasma levels and AUC value obtained after treatement with extract of uncomplexed curcumin [13]. Phospholipid complexes of proanthycynidins extracted from Vitis vinifera were prepared for use in suitable oral formulations, e.g. tablets or capsules, for treatment of atherosclerotic pathological conditions like myocardial and cerebaral infarctions [14].The phospholipid complexes of proanthocyanidin A2 (2:1 to 1:2 ratio) were significantly more useful for the prevention and the treatment of atherosclerosis lesions in rabbit [15]. Phospholipid complexes of extracts of Vitis vinifera, and phospholipid complexes of standardized extract from Centella asiatica were incorporated in pharmaceutical and cosmetic compositions for were described for prevention of skin aging [16].
Flavanolignane-phospholipid complexes with a molar ratio of 1:1 of silybin, silidianin and silicristin were prepared for oral administration for treatment of acute or chronic liver disease of toxic, metabolic and/or infective origin or of degenerative nature, and for prevention of liver damages resulting from the use of drugs and/or luxury substances injurious to the liver [17]. The pharmacological activity of the novel flavanolignane-phospholipid complexes was more evident and demonstrated even when orally administered thus overcoming the known problems of absorption common to many phenolic substances and particularly to silymarin.
Poor absorption by oral route, poor tolerability by cutaneous/topical administration and remarkable toxicity by parenteral route limits the therapeutic utility of saponins. Complexes of saponins with phospholipids allowed overcoming these drawbacks, particularly allowing an effective absorption by oral and topical route and a high stability, due to the lipophilic characteristics attained [18].Complex of flavonoids with phospholipids, characterized by high lipophilia and improved bio-availability and therapeutic properties as compared with free, not complexed flavonoids were prepared for use as the active principle in pharmaceutical and cosmetic compositions like tablets, capsules, creams, gels etc.[19].Complexes of extracts from Krameria triandra Ruiz et av. and other plants of the Eupomatia genus, as well as some phenol constituents thereof of neo-lignane or nor-neolignane nature, with phospholipids were prepared [20] for incorporation in the traditional pharmaceutical forms for the treatment of superficial infected inflammatory processes, in torpid sores and in all the phlogistic conditions of the oral cavity.
Complexes between natural or synthetic phospholipids and bilobalide, a sesquiterpene extracted from the leaves of Gingko biloba, were prepared for their application as antiinflammatory agents and as agents for the treatment of disorders associated with inflammatory or traumatic neuritic processes [21]. These complexes exhibited high bioavailability compared with free bilobalide, and were suitable for incorporation into pharmaceutical formulations for systemic and topical administration.
7. Conclusions
Phytosomes results from the reaction of a stoichiometric amount of the phospholipid (phosphatidylcholine) with the standardized extract or polyphenolic constituents (like flavonoids, terpenoids, tannins, xanthones) in a non-polar solvent. Phytosomes show better absorption profile and enhances delivery of phenolic phytoconstituents to the tissues. The complexation of phenolic phytoconstituents and phospholipids makes the pheolic phytoconstituents more stable in the complex form due to liopophilic nature. Both improvement in absorption and increase of stability reduce the amount of active constituents required in formulating an appropriate dosage form when compared to the products obtained from conventional plant extracts. Hence, several excellent phenolic phytoconstituents have been successfully formulated and delivered in this way exhibiting remarkable therapeutic efficacy in animal as well as in human models. Numerous phytosomal products have been commercially introduced and churning out appreciable profits to the pharmaceutical, neutraceutical or cosmetic manufacturers.
References
[1] Bhattacharya S. Phytosomes: emerging strategy in delivery of herbal drugs and nutraceuticals. Pharma Times 2009; 41: 9-12.
[9] Bhattacharya S. Phytosomes: the new technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Health Res 2009; 2: 225-9.
[10] Vasanti M. Phytosomes: a short review. Biol Online 2008; NUMBER: PAGES
[11] Patel J, Patel R, Khambholja K, Patel N. An overview of phytosomes as an advanced herbal drug delivery system. Asian J Pharm Sci 2009; 4: 363-71.
[12] Franceschi F, Giori A. Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability. Indena Spa, Milano, Italy 2007, Patent No. WO 2007/118631.
[13] Giori A, Franceschi F. Phospholipid complexes of curcumin having improved bioavailability. Indena Spa, Milano, Italy 2007, Patent No. WO 2007/101551.
[14] Morazzoni P, Bombardelli E. Phospholipid complexes prepared from extracts of vitis vinifera as anti-atherosclerotic agents. Indena Spa, Milan, Italy 2001, Patent No. US6297218.
[15] Bombardelli E, Morazzoni P. Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents. Indena Spa, Milan, Italy 2002, Patent No. US 6429202.
[16] Bombardelli E. Oral compositions for the treatment of cellulite. Indena Spa, Milano, Italy 2010, Patent No. US 7691422.
[17] Gabetta B, Bombardelli, Ezio, Pifferi, Giorgio. Complexes of flavanolignanes with phospholipids, preparation thereof and associated pharmaceutical compositions. Inverni, Della Beffa Spa, Italy 1987, Patent No. EP 0209038.
[18] Bombardelli E, Patri, Gian Franco, Pozzi, Roberto. Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them. Indena Spa, Milano, Italy 1988, Patent No. EP 0283713.
[19] Bombardelli E, Patri GF. Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them. Indena Spa, Milano, Italy 1993, Patent No. EP 0275005.
[20] Bombardelli E, Patri G, Pozzi R. Complexes of neolignane derivatives with phospholipids, the use thereof and pharmaceutical and cosmetic formulations containing them. Indena Spa, Milano, Italy 1992, Patent No. EP 0464297.
[21] Bombardelli E, Mustich G. Bilobalide phospholipide complexes, their applications and formulations containing them. Indena Spa, Milano, Italy 1991, Patent No. EP 0441279.
[22] Silybin-phosphatidylcholine complex. Altern Med Rev 2009; 14: 385-90.
[23] Tedesco D, Tedesco D SS, Galletti S, Tameni M, Sonzogni O, Ravarotto L. Efficacy of silymarin-phospholipid complex in reducing the toxicity of aflatoxin b1 in broiler chicks. Poult Sci 2004; 83: 1839-43.
[24] Farinacci M, Gaspardo B, Colitti M, Stefanon B. Dietary administration of curcumin modifies transcriptional profile of genes involved in inflammatory cascade in horse leukocytes. Italian J Animal Sci 2009; 8: 84-6.
[25] Di Pierro F, Menghi A, Barreca A, Lucarelli M, Calandrelli A. Greenselect® phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Alt Med Rev 2009; 14: 154-60.
[26] Naik S, Pilgaonkar V, Panda V. Evaluation of antioxidant activity of ginkgo biloba phytosomes in rat brain. Phytotherapy Res 2006; 20: 1013-6.
[28] Bombardeli E, Bonati A, Gabetta B, Mustich G. Triterpenoids of terminalia sericea. Phytochemistry 1974; 13: 2559-62.
[29] Kohli K, Ali J, Ansari M, Raheman Z. Curcumin: a natural anti-inflammatory agent. Ind J Pharmacol 2005; 37: 141-7.
[30] Maiti K, Mukherjee K, Gantait A, Saha B, PK M. Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol 2006; 58: 1227-33.
[31] Semalty A, Semalty M, Singh R, Saraf S, Saraf S. Development and characterization of phytosomes of novel xanthones isolated alternifolia for improving the bioavailability. AAPS Annual Meeting and Exposition 2007; PAGES.
[33] Guang-xi Z, Hongxiang L, Dianzhou B. Interaction of puerarin with phospholipid in solid dispersion. Chin Pharm J 2003; 12: 36-40.
[34] Chang Y, Hsieh C-Y, Peng Z-A, Yen T-L, Hsiao G, Chou D-S, Chen C-M, Sheu J-R. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci 2009; 16: 9.
[35] Li Y, Pan W, Chen S, Xu H, Yang D, ASC C. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. Drug Dev Ind Pharm 2006; 32: 413-22.
[36] Li Y, Yang D-J, Chen S-L, Chen S-B, Chan AS-C. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation. Internat J Pharm 2008; 359: 35-45.